Dose-Response Relationship
Definition
How a drug's effect changes with its dose. Trials use it to find the dose that gives the most benefit with acceptable safety.
Dose-Response Relationship
The dose-response relationship is a core idea in pharmacology: how the size of a drug’s effect changes as the dose changes. In drug development, mapping it is essential for choosing doses for large Phase 3 trials. A clear dose-response signal, where higher doses produce bigger effects, is strong evidence that the benefit comes from the drug and not chance. It also helps regulators weigh benefit against risk at each dose level.
Phase 2 dose-ranging trials are built to map the dose-response curve by testing several doses against placebo. Researchers look for the lowest effective dose, the dose at which the benefit levels off (the ceiling effect) and the dose beyond which side effects rise faster than the extra benefit. An ideal profile shows efficacy rising steeply at first, then leveling off, where higher doses add less and less benefit while side effects keep climbing.
Retatrutide showed a very clear dose-response relationship in Phase 2. In the obesity trial, weight loss rose steadily from -8.7% at 1 mg to -24.2% at 12 mg over 48 weeks, and the top dose group’s weight loss curve was still falling when the study ended. In the type 2 diabetes trial, HbA1c reductions ranged from -1.39% at 1 mg to -2.02% at 12 mg. This consistent pattern in both conditions supported choosing higher doses for the Phase 3 TRIUMPH program and strengthened the case that retatrutide itself caused the clinical results.